{"id":"https://openalex.org/W4382010685","doi":"https://doi.org/10.1111/bjh.18953","title":"Patient\u2010derived xenograft models of ALK + ALCL reveal preclinical promise for therapy with brigatinib","display_name":"Patient\u2010derived xenograft models of ALK + ALCL reveal preclinical promise for therapy with brigatinib","alternate_titles":[],"publication_year":2023,"publication_date":"2023-06-25","ids":{"openalex":"https://openalex.org/W4382010685","doi":"https://doi.org/10.1111/bjh.18953","pmid":"https://pubmed.ncbi.nlm.nih.gov/37357529","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10952693"},"language":"en","primary_location":{"id":"doi:10.1111/bjh.18953","doi":"https://doi.org/10.1111/bjh.18953","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.18953","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.18953","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4382010685"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.18953","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071036420","display_name":"Nina Prokoph","orcid":"https://orcid.org/0000-0002-6429-9895","observed_orcids":["https://orcid.org/0000-0002-6429-9895"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nina Prokoph","raw_affiliation_strings":["Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009137383","display_name":"Jamie D. Matthews","orcid":"https://orcid.org/0000-0002-2980-8615","observed_orcids":["https://orcid.org/0000-0002-2980-8615"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jamie D. Matthews","raw_affiliation_strings":["Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015272467","display_name":"Ricky M. Trigg","orcid":"https://orcid.org/0000-0001-9329-9344","observed_orcids":["https://orcid.org/0000-0001-9329-9344"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ricky M. Trigg","raw_affiliation_strings":["Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085517110","display_name":"Ivonne Aidee Montes-Mojarro","orcid":"https://orcid.org/0000-0003-0636-7623","observed_orcids":["https://orcid.org/0000-0003-0636-7623"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ivonne A. Montes\u2010Mojarro","raw_affiliation_strings":["Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen University Hospital T\u00fcbingen, Eberhard\u2010Karls\u2010University  T\u00fcbingen Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen University Hospital T\u00fcbingen, Eberhard\u2010Karls\u2010University  T\u00fcbingen Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007094258","display_name":"G.A. Amos Burke","orcid":"https://orcid.org/0000-0003-2671-9972","observed_orcids":["https://orcid.org/0000-0003-2671-9972"]},"institutions":[{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. A. Amos Burke","raw_affiliation_strings":["Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0003-2671-9972","affiliations":[{"raw_affiliation_string":"Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK","institution_ids":["https://openalex.org/I2802466933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030552991","display_name":"Falko Fend","orcid":"https://orcid.org/0000-0002-5496-293X","observed_orcids":["https://orcid.org/0000-0002-5496-293X"]},"institutions":[{"id":"https://openalex.org/I8087733","display_name":"University of T\u00fcbingen","ror":"https://ror.org/03a1kwz48","country_code":"DE","type":"education","lineage":["https://openalex.org/I8087733"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Falko Fend","raw_affiliation_strings":["Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen University Hospital T\u00fcbingen, Eberhard\u2010Karls\u2010University  T\u00fcbingen Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pathology and Neuropathology and Comprehensive Cancer Center T\u00fcbingen University Hospital T\u00fcbingen, Eberhard\u2010Karls\u2010University  T\u00fcbingen Germany","institution_ids":["https://openalex.org/I8087733"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052133938","display_name":"Olaf Merkel","orcid":"https://orcid.org/0000-0001-5089-344X","observed_orcids":["https://orcid.org/0000-0001-5089-344X"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Olaf Merkel","raw_affiliation_strings":["Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048087410","display_name":"Lukas Kenner","orcid":"https://orcid.org/0000-0003-2184-1338","observed_orcids":["https://orcid.org/0000-0003-2184-1338"]},"institutions":[{"id":"https://openalex.org/I150540706","display_name":"University of Veterinary Medicine Vienna","ror":"https://ror.org/01w6qp003","country_code":"AT","type":"education","lineage":["https://openalex.org/I150540706"]},{"id":"https://openalex.org/I4210128031","display_name":"Center For Biomarker Research In Medicine","ror":"https://ror.org/031gwf224","country_code":"AT","type":"nonprofit","lineage":["https://openalex.org/I4210128031"]},{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lukas Kenner","raw_affiliation_strings":["Center for Biomarker Research in Medicine (CBmed) Vienna, Core-Lab2, Medical University of Vienna, Vienna, Austria","Christian Doppler Laboratory for Applied Metabolomics, Medical University of Vienna, Vienna, Austria","Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria","Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Biomarker Research in Medicine (CBmed) Vienna, Core-Lab2, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I4210128031","https://openalex.org/I76134821"]},{"raw_affiliation_string":"Christian Doppler Laboratory for Applied Metabolomics, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"Department of Experimental Pathology and Laboratory Animal Pathology, Institute of Clinical Pathology, Medical University of Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I76134821"]},{"raw_affiliation_string":"Unit of Laboratory Animal Pathology, University of Veterinary Medicine Vienna, Vienna, Austria","institution_ids":["https://openalex.org/I150540706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051922909","display_name":"Birgit Geoerger","orcid":"https://orcid.org/0000-0003-4361-3643","observed_orcids":["https://orcid.org/0000-0003-4361-3643"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I277688954","display_name":"Universit\u00e9 Paris-Saclay","ror":"https://ror.org/03xjwb503","country_code":"FR","type":"education","lineage":["https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405255793","display_name":"Immunologie anti-tumorale et immunoth\u00e9rapie des cancers","ror":"https://ror.org/03e75qp68","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802","https://openalex.org/I4405255793"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Birgit Geoerger","raw_affiliation_strings":["Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France","INSERM U1015, Gustave Roussy Cancer Center Universit\u00e9 Paris\u2010Saclay  Villejuif France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]},{"raw_affiliation_string":"INSERM U1015, Gustave Roussy Cancer Center Universit\u00e9 Paris\u2010Saclay  Villejuif France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I277688954","https://openalex.org/I2801843802","https://openalex.org/I4405255793"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert Johnston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801044184","display_name":"Royal Belfast Hospital for Sick Children","ror":"https://ror.org/01cv0eh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1289110261","https://openalex.org/I2801044184"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert Johnston","raw_affiliation_strings":["Department of Paediatric Oncology/Haematology, Royal Belfast Hospital for Sick Children, Belfast, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatric Oncology/Haematology, Royal Belfast Hospital for Sick Children, Belfast, UK","institution_ids":["https://openalex.org/I2801044184"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085468231","display_name":"Matthew Jonathan Murray","orcid":"https://orcid.org/0000-0002-4480-1147","observed_orcids":["https://orcid.org/0000-0002-4480-1147"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I2802466933","display_name":"Cambridge University Hospitals NHS Foundation Trust","ror":"https://ror.org/04v54gj93","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew J. Murray","raw_affiliation_strings":["Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK","Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK"],"raw_orcid":"https://orcid.org/0000-0002-4480-1147","affiliations":[{"raw_affiliation_string":"Department of Paediatric Haematology and Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK","institution_ids":["https://openalex.org/I2802466933"]},{"raw_affiliation_string":"Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092262057","display_name":"Charlotte Riguad","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Charlotte Riguad","raw_affiliation_strings":["Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002010740","display_name":"Laurence Brugi\u00e8res","orcid":"https://orcid.org/0000-0002-7798-6651","observed_orcids":["https://orcid.org/0000-0002-7798-6651"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laurence Brugi\u00e8res","raw_affiliation_strings":["Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Center, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061095336","display_name":"Suzanne Dawn Turner","orcid":"https://orcid.org/0000-0002-8439-4507","observed_orcids":["https://orcid.org/0000-0002-8439-4507"]},"institutions":[{"id":"https://openalex.org/I21449261","display_name":"Masaryk University","ror":"https://ror.org/02j46qs45","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21449261"]},{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]},{"id":"https://openalex.org/I4210156194","display_name":"Addenbrooke's Hospital","ror":"https://ror.org/055vbxf86","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802466933","https://openalex.org/I4210156194"]}],"countries":["CZ","GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Suzanne D. Turner","raw_affiliation_strings":["Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK","Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic"],"raw_orcid":"https://orcid.org/0000-0002-8439-4507","affiliations":[{"raw_affiliation_string":"Division of Cellular and Molecular Pathology, Department of Pathology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK","institution_ids":["https://openalex.org/I241749","https://openalex.org/I4210156194"]},{"raw_affiliation_string":"Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic","institution_ids":["https://openalex.org/I21449261"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":14,"corresponding_author_ids":["https://openalex.org/A5061095336"],"corresponding_institution_ids":["https://openalex.org/I21449261","https://openalex.org/I241749","https://openalex.org/I4210156194"],"apc_list":{"value":4940,"currency":"USD","value_usd":4940},"apc_paid":{"value":4940,"currency":"USD","value_usd":4940},"fwci":1.3562,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.79114944,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"202","issue":"5","first_page":"985","last_page":"994"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.4009000062942505,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.4009000062942505,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.19249999523162842,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.1793999969959259,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anaplastic-large-cell-lymphoma","display_name":"anaplastic large cell lymphoma","score":0.9800000190734863},{"id":"https://openalex.org/keywords/anaplastic-lymphoma-kinase","display_name":"anaplastic lymphoma kinase","score":0.9120000004768372},{"id":"https://openalex.org/keywords/brigatinib","display_name":"brigatinib","score":0.9639999866485596},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cns-relapse","display_name":"central nervous system relapse","score":0.8410000205039978},{"id":"https://openalex.org/keywords/pediatric-lymphoma","display_name":"pediatric lymphoma","score":0.7590000033378601},{"id":"https://openalex.org/keywords/crizotinib-resistance","display_name":"crizotinib resistance","score":0.9850000143051147},{"id":"https://openalex.org/keywords/p53-loss","display_name":"p53 deficiency","score":0.9819999933242798},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.8650000095367432},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.6439999938011169}],"concepts":[{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.9781477451324463},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.7839008569717407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7286936044692993},{"id":"https://openalex.org/C2777872185","wikidata":"https://www.wikidata.org/wiki/Q486090","display_name":"Anaplastic large-cell lymphoma","level":3,"score":0.5878333449363708},{"id":"https://openalex.org/C2778347629","wikidata":"https://www.wikidata.org/wiki/Q4652380","display_name":"ALK inhibitor","level":5,"score":0.5146118402481079},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.49813055992126465},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.48150333762168884},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.41176074743270874},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39612042903900146},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.38850587606430054},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38175874948501587},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3702133893966675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3501613736152649},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077547","descriptor_name":"Crizotinib","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000077547","descriptor_name":"Crizotinib","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000077548","descriptor_name":"Anaplastic Lymphoma Kinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009943","descriptor_name":"Organophosphorus Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009943","descriptor_name":"Organophosphorus Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017728","descriptor_name":"Lymphoma, Large-Cell, Anaplastic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D017728","descriptor_name":"Lymphoma, Large-Cell, Anaplastic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D020794","descriptor_name":"Receptor Protein-Tyrosine Kinases","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D064593","descriptor_name":"Heterografts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":8,"locations":[{"id":"doi:10.1111/bjh.18953","doi":"https://doi.org/10.1111/bjh.18953","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.18953","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.18953","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10952693","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10952693","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Haematol","raw_type":"Text"},{"id":"pmid:37357529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37357529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of haematology","raw_type":"Journal Article"},{"id":"pmh:oai:is.muni.cz:2368982","doi":null,"is_oa":true,"landing_page_url":"https://is.muni.cz/publication/2368982","pdf_url":null,"source":{"id":"https://openalex.org/S4306400102","display_name":"Ve\u0159ejn\u00e9 slu\u017eby Informa\u010dn\u00edho syst\u00e9mu (Masarykiana Brunensis Universitas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"British journal of haematology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/f74edd3b-3c8b-42e3-b109-96d6708c0a5f","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/files/216995663/Br_J_Haematol_-_2023_-_Prokoph_-_Patient_derived_xenograft_models_of_ALK_ALCL_reveal_preclinical_promise_for_therapy_with.pdf","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Prokoph, N, Matthews, J D, Trigg, R M, Montes-Mojarro, I A, Burke, G A A, Fend, F, Merkel, O, Kenner, L, Geoerger, B, Johnston, R, Murray, M J, Riguad, C, Brugi\u00e8res, L & Turner, S D 2023, 'Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib', British Journal of Haematology, vol. 202, no. 5, pp. 985-994. https://doi.org/10.1111/bjh.18953","raw_type":"article"},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/350947","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/350947","pdf_url":null,"source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:www.repository.cam.ac.uk:1810/354152","doi":null,"is_oa":true,"landing_page_url":"https://www.repository.cam.ac.uk/handle/1810/354152","pdf_url":null,"source":{"id":"https://openalex.org/S4306401777","display_name":"Apollo (University of Cambridge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I241749","host_organization_name":"University of Cambridge","host_organization_lineage":["https://openalex.org/I241749"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"doi:10.17863/cam.97193","doi":"https://doi.org/10.17863/cam.97193","is_oa":true,"landing_page_url":"https://doi.org/10.17863/cam.97193","pdf_url":null,"source":{"id":"https://openalex.org/S7407050737","display_name":"Apollo","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1111/bjh.18953","doi":"https://doi.org/10.1111/bjh.18953","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bjh.18953","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.18953","source":{"id":"https://openalex.org/S153015021","display_name":"British Journal of Haematology","issn_l":"0007-1048","issn":["0007-1048","1365-2141"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Haematology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G139696651","display_name":null,"funder_award_id":"(BRC-1215-20014)","funder_id":"https://openalex.org/F4320336709","funder_display_name":"NIHR Cambridge Biomedical Research Centre"},{"id":"https://openalex.org/G1960665002","display_name":null,"funder_award_id":"A25117","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G2129858602","display_name":null,"funder_award_id":"PHRC-K14-175","funder_id":"https://openalex.org/F4320323807","funder_display_name":"Institut National Du Cancer"},{"id":"https://openalex.org/G299057155","display_name":null,"funder_award_id":"[IS-BRC-1215-20014","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G370598735","display_name":null,"funder_award_id":"BRC1215-20014","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G4637812876","display_name":"PDGFRB function in lymphoma progression","funder_award_id":"P29251","funder_id":"https://openalex.org/F4320321181","funder_display_name":"Austrian Science Fund"},{"id":"https://openalex.org/G544954095","display_name":null,"funder_award_id":"[C9685/A25117]","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320321181","display_name":"Austrian Science Fund","ror":"https://ror.org/013tf3c58"},{"id":"https://openalex.org/F4320323807","display_name":"Institut National Du Cancer","ror":"https://ror.org/03m8vkq32"},{"id":"https://openalex.org/F4320324826","display_name":"Institut Gustave-Roussy","ror":"https://ror.org/0321g0743"},{"id":"https://openalex.org/F4320334322","display_name":"HORIZON EUROPE Framework Programme","ror":null},{"id":"https://openalex.org/F4320336709","display_name":"NIHR Cambridge Biomedical Research Centre","ror":"https://ror.org/05m8dr349"},{"id":"https://openalex.org/F4320338438","display_name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4382010685.pdf","grobid_xml":"https://content.openalex.org/works/W4382010685.grobid-xml"},"referenced_works_count":44,"referenced_works":["https://openalex.org/W1939376872","https://openalex.org/W1968235930","https://openalex.org/W1993428519","https://openalex.org/W1997476230","https://openalex.org/W2004899483","https://openalex.org/W2007739717","https://openalex.org/W2019108602","https://openalex.org/W2038586807","https://openalex.org/W2054981415","https://openalex.org/W2062054245","https://openalex.org/W2070098787","https://openalex.org/W2074833317","https://openalex.org/W2105124247","https://openalex.org/W2111893233","https://openalex.org/W2130433179","https://openalex.org/W2147038864","https://openalex.org/W2160516333","https://openalex.org/W2168133698","https://openalex.org/W2333888126","https://openalex.org/W2561527502","https://openalex.org/W2610816290","https://openalex.org/W2613260339","https://openalex.org/W2624310346","https://openalex.org/W2742652175","https://openalex.org/W2765831845","https://openalex.org/W2767072667","https://openalex.org/W2769382437","https://openalex.org/W2782582628","https://openalex.org/W2804974301","https://openalex.org/W2805583487","https://openalex.org/W3019507878","https://openalex.org/W3037378367","https://openalex.org/W3041552037","https://openalex.org/W3046021472","https://openalex.org/W3087892739","https://openalex.org/W3108724611","https://openalex.org/W3122109253","https://openalex.org/W3156145428","https://openalex.org/W4213041713","https://openalex.org/W4220935578","https://openalex.org/W4280581693","https://openalex.org/W4288969861","https://openalex.org/W4311589598","https://openalex.org/W4311916201"],"related_works":["https://openalex.org/W4366261453","https://openalex.org/W4379980880","https://openalex.org/W4386067427","https://openalex.org/W2764222289","https://openalex.org/W2322259620","https://openalex.org/W2791064144","https://openalex.org/W2804764624","https://openalex.org/W2612562629","https://openalex.org/W4415058076"],"abstract_inverted_index":{"Anaplastic":[0],"large-cell":[1],"lymphoma":[2,14],"(ALCL)":[3],"is":[4,125,145],"a":[5,39,46,95,150,157,167],"T-cell":[6],"malignancy":[7],"predominantly":[8],"driven":[9],"by":[10],"the":[11,61,65,80,114,129,154],"oncogenic":[12],"anaplastic":[13],"kinase":[15],"(ALK),":[16],"accounting":[17],"for":[18],"approximately":[19],"15%":[20],"of":[21,43,49,60,82,116,131,134,156],"all":[22],"paediatric":[23,87],"non-Hodgkin":[24],"lymphoma.":[25],"Patients":[26],"with":[27,38],"central":[28],"nervous":[29],"system":[30],"(CNS)":[31],"relapse":[32,108],"are":[33,90],"particularly":[34],"difficult":[35],"to":[36,112,147,153,164],"treat":[37],"3-year":[40],"overall":[41],"survival":[42,48],"49%":[44],"and":[45,69,141],"median":[47],"23.5":[50],"months.":[51],"The":[52],"second-generation":[53],"ALK":[54],"inhibitor":[55],"brigatinib":[56,83,124,165],"shows":[57],"superior":[58,146],"penetration":[59],"blood-brain":[62],"barrier":[63],"unlike":[64],"first-generation":[66],"drug":[67],"crizotinib":[68,148],"has":[70],"shown":[71],"promising":[72],"results":[73],"in":[74,84,121,127],"ALK+":[75,88,101],"non-small-cell":[76],"lung":[77],"cancer.":[78],"However,":[79],"benefits":[81],"treating":[85],"aggressive":[86],"ALCL":[89,102,140,161],"largely":[91],"unknown.":[92],"We":[93,119],"established":[94],"patient-derived":[96],"xenograft":[97],"(PDX)":[98],"resource":[99],"from":[100],"patients":[103],"at":[104],"or":[105],"before":[106],"CNS":[107],"serving":[109],"as":[110,149,166],"models":[111,133],"facilitate":[113],"development":[115],"future":[117,168],"therapies.":[118],"show":[120],"vivo":[122],"that":[123,143],"effective":[126],"inducing":[128],"remission":[130],"PDX":[132,162],"crizotinib-resistant":[135],"(ALK":[136],"C1156Y,":[137],"TP53":[138],"loss)":[139],"furthermore":[142],"it":[144],"second-line":[151],"approach":[152],"treatment":[155],"standard":[158],"chemotherapy":[159],"relapsed/refractory":[160],"pointing":[163],"therapeutic":[169],"option.":[170]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4382010685","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2023-06-27T00:00:00"}
